Synthesis and in vitro evaluation of 3-substituted-1-azaanthraquinones

Bioorganic & Medicinal Chemistry Letters
1996.0

Abstract

In the course of developing novel antitumor agents, we synthesized 3-substituted-1 azaanthraquinones, incorporating the alkylating or latent alkylating substituents as potential antitumor agents. The most active comound 4 exhibited cytotoxic activity comparable to that of doxorubicin. The compounds 3- 8 retained much of their activity against the doxorubicin-resistant cell line (MCF7/R).

Knowledge Graph

Similar Paper

Synthesis and in vitro evaluation of 3-substituted-1-azaanthraquinones
Bioorganic & Medicinal Chemistry Letters 1996.0
Synthesis and structure–activity relationships of 1,5-diazaanthraquinones as antitumour compounds
Bioorganic & Medicinal Chemistry Letters 2004.0
Overcoming doxorubicin-resistance in the NCI/ADR-RES model cancer cell line by novel anthracene-9,10-dione derivatives
Bioorganic & Medicinal Chemistry Letters 2013.0
Synthesis and in vitro cytotoxicity of 3-substituted-1,8-diazaanthraquinones produced by Lewis-acid catalyzed hetero diels-alder reaction
Bioorganic & Medicinal Chemistry Letters 1998.0
Doxorubicin analogs incorporating chemically reactive substituents
Journal of Medicinal Chemistry 1991.0
Antitumor Agents. 181. Synthesis and Biological Evaluation of 6,7,2‘,3‘,4‘-Substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a New Class of Antimitotic Antitumor Agents
Journal of Medicinal Chemistry 1998.0
Synthesis and antitumor activity of isodoxorubicin analogs
Journal of Medicinal Chemistry 1993.0
6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A Novel Class of Chromophore-Modified Antitumor Anthracene-9,10-diones: Synthesis and Antitumor Evaluations
Journal of Medicinal Chemistry 1994.0
Synthesis and Cytotoxic Evaluation of Novel Spirohydantoin Derivatives of the Dihydrothieno[2,3-b]naphtho-4,9-dione System
Journal of Medicinal Chemistry 2005.0
Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents
European Journal of Medicinal Chemistry 2010.0